4.4 Review

Novel insights in the genetics of steroid-sensitive nephrotic syndrome in childhood

Journal

PEDIATRIC NEPHROLOGY
Volume 36, Issue 8, Pages 2165-2175

Publisher

SPRINGER
DOI: 10.1007/s00467-020-04780-4

Keywords

Steroid-sensitive nephrotic syndrome; SSNS; Genetics; Paediatrics; HLA; GWAS; CALHM6

Funding

  1. St. Peter's Trust for Kidney, Bladder, & Prostate Research
  2. KRESCENT Post-Doctoral Fellowship from the Kidney Foundation of Canada

Ask authors/readers for more resources

Steroid-sensitive nephrotic syndrome (SSNS) is the most common form of nephrotic syndrome in childhood, with growing evidence of a genetic component in disease susceptibility. Familial clustering and genetic studies have not yet provided conclusive evidence of Mendelian inheritance, suggesting a complex inheritance pattern involving multiple genetic variants and environmental interactions in disease development. Genome-wide association studies (GWASs) have shed new light on the genetics of SSNS, contributing to our understanding of its pathogenesis.
Steroid-sensitive nephrotic syndrome (SSNS) is the most common form of nephrotic syndrome in childhood and there is growing evidence that genetics play a role in the susceptibility for the disease. Familial clustering has been observed and has led to several studies on familial SSNS trying to identify a monogenic cause of the disease. Until now, however, none of these have provided convincing evidence for Mendelian inheritance. This and the phenotypic variability within SSNS suggest a complex inheritance pattern, where multiple variants and interactions between those and the environment play roles in disease development. Genome-wide association studies (GWASs) have been used to investigate this complex disease. We herein highlight new insights in the genetics of the disease provided by GWAS and identify how these insights fit into our understanding of the pathogenesis of SSNS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Correction Urology & Nephrology

Digenic Alport Syndrome (vol 17, pg 1697, 2022)

J. Savige, A. Renieri, E. Ars, S. Daga, A. M. Pinto, H. Rothe, D. P. Gale, M. Aksenova, A. Cerkauskaite, O. Bielska, B. Lipska-Zietkiewicz, J. T. Gibson

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Correction Biochemistry & Molecular Biology

The 2019 and 2021 International workshops on Alport syndrome (vol 30, 507, 2022)

Sergio Daga, Jie Ding, Constantinos Deltas, Judy Savige, Beata S. Lipska-Zietkiewicz, Julia Hoefele, Frances Flinter, Daniel P. Gale, Marina Aksenova, Hirofumi Kai, Laura Perin, Moumita Barua, Roser Torra, Jeff H. Miner, Laura Massella, Danica Galesic Ljubanovic, Rachel Lennon, Andre B. Weinstock, Bertrand Knebelmann, Agne Cerkauskaite, Susie Gear, Oliver Gross, A. Neil Turner, Margherita Baldassarri, Anna Maria Pinto, Alessandra Renieri

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Transplantation

Clinical and genetic characteristics of Dent's disease type 1 in Europe

Carla Burballa, Gerard Cantero-Recasens, Larisa Prikhodina, Francesca Lugani, Karlpeter Schlingmann, Petr Ananin, Martine Besouw, Detlef Bockenhauer, Leire Madariaga, Aurelia Bertholet-Thomas, Francesca Taroni, Mattia Parolin, Peter Conlon, Francesco Emma, Dorella Del Prete, Dominique Chauveau, Linda Koster-Kamphuis, Marc Fila, Andrea Pasini, Isabel Castro, Giacomo Colussi, Marta Gil, Barian Mohidin, Tanja Wlodkowski, Franz Schaefer, Gema Ariceta

Summary: DD1 is a rare X-linked nephropathy caused by CLCN5 mutations, characterized by proximal tubule dysfunction. Current management is symptomatic and does not prevent disease progression. This study investigated the clinical features and mutation spectra of DD1 patients in Europe, highlighting the unmet needs in diagnosis and treatment.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Pediatrics

Shared genetic risk across different presentations of gene test-negative idiopathic nephrotic syndrome

Mallory L. Downie, Sanjana Gupta, Melanie M. Y. Chan, Omid Sadeghi-Alavijeh, Jingjing Cao, Rulan S. Parekh, Carmen Bugarin Diz, Agnieszka Bierzynska, Adam P. Levine, Ruth J. Pepper, Horia Stanescu, Moin A. Saleem, Robert Kleta, Detlef Bockenhauer, Ania B. Koziell, Daniel P. Gale

Summary: A genetic risk score can help classify patients with INS presenting in different ways when monogenic causes are excluded.

PEDIATRIC NEPHROLOGY (2023)

Review Urology & Nephrology

The Impact of Tax Policy on Performance of Green Energy in Power Industry

Naima Smeulders, Alexander Cho, Abdulelah Alshaiban, Katharine Read, Aisling Fagan, Marina Easty, Kishore Minhas, Alex Barnacle, Wesley Hayes, Detlef Bockenhauer

Summary: Urinary stone disease is common in adults but rare in children. Children with stone disease require specialized treatment due to their unique characteristics.

KIDNEY INTERNATIONAL REPORTS (2023)

Article Urology & Nephrology

Long-Term Outcomes in IgA Nephropathy

David Pitcher, Fiona Braddon, Bruce Hendry, Alex Mercer, Kate Osmaston, Moin A. A. Saleem, Retha Steenkamp, Katie Wong, A. Neil Turner, Kaijun Wang, Daniel P. P. Gale, Jonathan Barratt

Summary: Background IgA nephropathy can progress to kidney failure, and risk assessment soon after diagnosis has advantages both for clinical management and the development of new therapeutics. We present relationships among proteinuria, eGFR slope, and lifetime risks for kidney failure. The study found that almost all patients were at risk of progression to kidney failure within their expected lifetime unless a rate of eGFR loss <= 1 ml/min per 1.73 m(2) per year was maintained.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Medicine, General & Internal

Genomics in the kidney clinic

Gabriel T. Doctor, Daniel P. Gale, Melanie M. Y. Chan

Summary: Inherited diseases are a common cause of end-stage kidney disease, and clinical genomic testing is becoming more available in the UK. Eligible patients in England can be referred through the NHS Genomic Medicine Service. Testing is useful for diagnosing, predicting the prognosis, and managing conditions such as autosomal dominant polycystic kidney disease (ADPKD), Alport syndrome, autosomal dominant tubulointerstitial kidney disease (ADTKD), and focal segmental glomerulosclerosis (FSGS).

CLINICAL MEDICINE (2023)

Article Genetics & Heredity

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

Krzysztof Kiryluk, Elena Sanchez-Rodriguez, Xu-Jie Zhou, Francesca Zanoni, Lili Liu, Nikol Mladkova, Atlas Khan, Maddalena Marasa, Jun Y. Zhang, Olivia Balderes, Simone Sanna-Cherchi, Andrew S. Bomback, Pietro A. Canetta, Gerald B. Appel, Jai Radhakrishnan, Hernan Trimarchi, Ben Sprangers, Daniel C. Cattran, Heather Reich, York Pei, Pietro Ravani, Kresimir Galesic, Dita Maixnerova, Vladimir Tesar, Benedicte Stengel, Marie Metzger, Guillaume Canaud, Nicolas Maillard, Francois Berthoux, Laureline Berthelot, Evangeline Pillebout, Renato Monteiro, Raoul Nelson, Robert J. Wyatt, William Smoyer, John Mahan, Al-Akash Samhar, Guillermo Hidalgo, Alejandro Quiroga, Patricia Weng, Raji Sreedharan, David Selewski, Keefe Davis, Mahmoud Kallash, Tetyana L. Vasylyeva, Michelle Rheault, Aftab Chishti, Daniel Ranch, Scott E. Wenderfer, Dmitry Samsonov, Donna J. Claes, Oleh Akchurin, Dimitrios Goumenos, Maria Stangou, Judit Nagy, Tibor Kovacs, Enrico Fiaccadori, Antonio Amoroso, Cristina Barlassina, Daniele Cusi, Lucia Del Vecchio, Giovanni Giorgio Battaglia, Monica Bodria, Emanuela Boer, Luisa Bono, Giuliano Boscutti, Gianluca Caridi, Francesca Lugani, GianMarco Ghiggeri, Rosanna Coppo, Licia Peruzzi, Vittoria Esposito, Ciro Esposito, Sandro Feriozzi, Rosaria Polci, Giovanni Frasca, Marco Galliani, Maurizio Garozzo, Adele Mitrotti, Loreto Gesualdo, Simona Granata, Gianluigi Zaza, Francesco Londrino, Riccardo Magistroni, Isabella Pisani, Andrea Magnano, Carmelita Marcantoni, Piergiorgio Messa, Renzo Mignani, Antonello Pani, Claudio Ponticelli, Dario Roccatello, Maurizio Salvadori, Erica Salvi, Domenico Santoro, Guido Gembillo, Silvana Savoldi, Donatella Spotti, Pasquale Zamboli, Claudia Izzi, Federico Alberici, Elisa Delbarba, Michal Florczak, Natalia Krata, Krzysztof Mucha, Leszek Paczek, Stanislaw Niemczyk, Barbara Moszczuk, Malgorzata Panczyk-Tomaszewska, Malgorzata Mizerska-Wasiak, Agnieszka Perkowska-Ptasinska, Teresa Baczkowska, Magdalena Durlik, Krzysztof Pawlaczyk, Przemyslaw Sikora, Marcin Zaniew, Dorota Kaminska, Magdalena Krajewska, Izabella Kuzmiuk-Glembin, Zbigniew Heleniak, Barbara Bullo-Piontecka, Tomasz Liberek, Alicja Debska-Slizien, Tomasz Hryszko, Anna Materna-Kiryluk, Monika Miklaszewska, Maria Szczepanska, Katarzyna Dyga, Edyta Machura, Katarzyna Siniewicz-Luzenczyk, Monika Pawlak-Bratkowska, Marcin Tkaczyk, Dariusz Runowski, Norbert Kwella, Dorota Drozdz, Ireneusz Habura, Florian Kronenberg, Larisa Prikhodina, David van Heel, Bertrand Fontaine, Chris Cotsapas, Cisca Wijmenga, Andre Franke, Vito Annese, Peter K. Gregersen, Sreeja Parameswaran, Matthew Weirauch, Leah Kottyan, John B. Harley, Hitoshi Suzuki, Ichiei Narita, Shin Goto, Hajeong Lee, Dong Ki Kim, Yon Su Kim, Jin-Ho Park, BeLong Cho, Murim Choi, Ans Van Wijk, Ana Huerta, Elisabet Ars, Jose Ballarin, Sigrid Lundberg, Bruno Vogt, Laila-Yasmin Mani, Yasar Caliskan, Jonathan Barratt, Thilini Abeygunaratne, Philip A. Kalra, Daniel P. Gale, Ulf Panzer, Thomas Rauen, Juergen Floege, Pascal Schlosser, Arif B. Ekici, Kai-Uwe Eckardt, Nan Chen, Jingyuan Xie, Richard P. Lifton, Ruth J. F. Loos, Eimear E. Kenny, Iuliana Ionita-Laza, Anna Koettgen, Bruce A. Julian, Jan Novak, Francesco Scolari, Hong Zhang, Ali G. Gharavi

Summary: Genome-wide association analyses have identified 30 risk loci for IgA nephropathy, a progressive form of kidney disease. Functional annotations of potential causal genes suggest inflammatory signaling pathways and cytokine ligand-receptor pairs as potential new drug targets. These findings provide valuable insights into the genetic basis of IgA nephropathy and offer potential avenues for developing therapeutic interventions.

NATURE GENETICS (2023)

Letter Pediatrics

Ascertaining pathogenicity of genetic variants: caution required

Zainab Arslan, Elizabeth Watson, Detlef Bockenhauer

PEDIATRIC NEPHROLOGY (2023)

Article Urology & Nephrology

Common Risk Variants in AHI1 Are Associated With Childhood Steroid Sensitive Nephrotic Syndrome

Mallory L. Downie, Sanjana Gupta, Catalin Voinescu, Adam P. Levine, Omid Sadeghi-Alavijeh, Stephanie Dufek-Kamperis, Jingjing Cao, Martin Christian, Jameela A. Kari, Shenal Thalgahagoda, Randula Ranawaka, Asiri Abeyagunawardena, Rasheed Gbadegesin, Rulan Parekh, Robert Kleta, Detlef Bockenhauer, Horia C. Stanescu, Daniel P. Gale

Summary: This study aimed to identify additional genetic loci associated with steroid-sensitive nephrotic syndrome (SSNS) in children. Through genome-wide association studies, the researchers found associations between the HLA-DQ/DR and AHI1 genes with SSNS. The AHI1 gene is involved in ciliary protein transport and immune dysregulation.

KIDNEY INTERNATIONAL REPORTS (2023)

Article Urology & Nephrology

Rare variants in the sodium-dependent phosphate transporter gene SLC34A3 explain missing heritability of urinary stone disease

Omid Sadeghi-Alavijeh, Melanie M. Y. Chan, Shabbir H. Moochhala, Sarah Howles, Daniel P. Gale, Detlef Bockenhauer

Summary: This study investigated the genetic factors of urinary stone disease and found that rare genetic variants in the SLC34A3 gene are associated with an increased risk of the disease. The effect size of this gene is intermediate between fully penetrant rare variants linked with Mendelian disorders and common variants associated with urinary stone disease.

KIDNEY INTERNATIONAL (2023)

Article Pediatrics

Tolvaptan and urea in paediatric hyponatraemia

Faidra Veligratli, Demitra Alexandrou, Sarit Shah, Rakesh Amin, Mehul Dattani, Hoong-Wei Gan, Adeola Famuboni, Camilo Lopez-Garcia, Richard Trompeter, Detlef Bockenhauer

Summary: This study retrospectively evaluated the efficacy and safety of tolvaptan and urea in treating pediatric SIADH. The results showed that both tolvaptan and urea were effective in normalizing plasma sodium concentration, and patients tolerated the treatment well without any unexpected side effects.

PEDIATRIC NEPHROLOGY (2023)

Article Genetics & Heredity

Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletions

Nikolai Tschernoster, Florian Erger, Stefan Kohl, Bjoern Reusch, Andrea Wenzel, Stephen Walsh, Holger Thiele, Christian Becker, Marek Franitza, Malte P. Bartram, Martin Koemhoff, Lena Schumacher, Christian Kukat, Tatiana Borodina, Claudia Quedenau, Peter Nuernberg, Markus M. Rinschen, Jan H. Driller, Bjorn P. Pedersen, Karl P. Schlingmann, Bruno Huettel, Detlef Bockenhauer, Bodo Beck, Janine Altmueller

Summary: In this study, long-read sequencing was used to analyze the structural variants in patients with Bartter syndrome type 3. A previously unknown common haplotype, which may predispose to additional events, was found to be significantly enriched in the patients with CLCNKB deletions. The spectrum of CLCNKB deletion alleles is broader than expected and likely still incomplete.

GENOME MEDICINE (2023)

Review Genetics & Heredity

Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice

Constantinos Deltas, Gregory Papagregoriou, Stavroula F. Louka, Apostolos Malatras, Frances Flinter, Daniel P. Gale, Susie Gear, Oliver Gross, Julia Hoefele, Rachel Lennon, Jeffrey H. Miner, Alessandra Renieri, Judy Savige, A. Neil Turner

Summary: Familial hematuria is a clinical sign of a genetically heterogeneous group of conditions, most commonly caused by pathogenic variants in the COL4A3/A4/A5 genes. The disease can lead to kidney failure, but the severity and progression vary among patients. Currently, it is still uncertain how to distinguish patients who require prompt medical intervention.

GENES (2023)

No Data Available